Uncategorised - European Medical Journal

prostate hyperplasia

Small-Volume BPH Surgical Treatment Outcomes

A recent clinical study found that TURP + TUIBN improves symptom scores and quality-of-life outcomes in patients with small-volume BPH.

Just 4,000 Daily Steps Linked to Lower Mortality in Older Women

Older women walking 4,000+ steps even 1–2 days a week had lower mortality and heart disease risk, showing small amounts of movement boost longevity.

gene therapy

Gene Therapy Shows Promise for Diabetic Kidney Disease

Gene therapy delivering protective vascular endothelial growth factor C into kidney filters reduced early diabetic kidney damage.

Patient receiving pulmonary tuberculosis therapy with rifampicin exposure focus

Rifampicin Levels Shape Tuberculosis Treatment Success

Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.

The Hidden Risk of Ghost Scans in Ultrasound

The Hidden Risk of Ghost Scans in Ultrasound

A major study exposes high ghost scan rates in trauma ultrasound, prompting urgent calls for improved quality control and clinician training.

Hospital burden of thrombotic events in systemic lupus erythematosus

Nationwide Study Exposes Thrombosis Burden in SLE

Thrombotic events remain a major driver of mortality and morbidity among patients with systemic lupus erythematosus.

melanoma

Nivolumab’s Lasting Edge Confirmed in Melanoma Trial

Nivolumab shows lasting melanoma recurrence prevention, with long-term safety, in largest-ever CheckMate 238 trial analysis.

pregnancy

Hyperemesis Gravidarum in Pregnancy Tied to Depression

New research finds women with hyperemesis gravidarum face higher risks of depression before and after pregnancy.

food allergy

Early Food Introduction Reduces Paediatric Food Allergy

These declines were observed regardless of atopic dermatitis diagnosis, indicating that early food introduction benefits both high-risk and general populations.

Expert Insights on HER2-Mutant NSCLC

Dr. Joshua Sabari explores recent advances in the treatment of HER2-mutant non-small cell lung cancer, including a newly FDA-approved option…